From XT.com’s Black Box to Hyperliquid’s Glass House — A Builder’s Journey
GRIDNET Magazine From XT.com’s Black Box toHyperliquid’s Glass House A Builder’s Journey How centralized exchanges weaponize market making rules to extract wealth...
Latest Content
The Expiry Day Trap: Inside Jane Street’s Alleged $4 Billion Manipulation of India’s Options Market
GRIDNET Magazine · Deep Dive The Expiry Day Trap: Inside Jane Street’s Alleged $4 Billion Manipulation of India’s Options Market Fifteen expiry...
One Child, One Edit, One Year: How Baby KJ Rewrote the Rules of Medicine
GRIDNET Magazine · Deep Dive One Child, One Edit, One Year: How Baby KJ Rewrote the Rules of Medicine Modern medicine was...
The New Colonialism Has No Flags: How Data Imperialism Is Reshaping Global Sovereignty
GRIDNET Magazine · Deep Dive The New Colonialism Has No Flags: How Data Imperialism Is Reshaping Global Sovereignty 144 nations have data...
The 70% Life Extension Nobody Is Talking About
The 70% Life Extension Nobody Is Talking About | GRIDNET Magazine The 70% Life Extension Nobody Is Talking About Two cheap drugs....
The Quantum Readability Problem Is Solved — And What It Means for Cryptography
The Quantum Readability Problem Is Solved — And What It Means for Cryptography | GRIDNET Magazine GRIDNET Magazine · Deep Dive The...
Zero-Knowledge Group Authentication in Decentralized WebRTC Swarms
In every human society, from the earliest campfire circles to modern boardrooms, there exists a fundamental tension between belonging and proving that...
The GRIDNET OS Swarms API — A Complete Developer’s Guide
In the grand arc of computing history, every paradigm shift has been preceded by a quietly revolutionary abstraction. The relational database gave...
The AI Accelerando — When Four Giants Speak in One Week, Listen
The Accelerando Begins: Why February 2026 May Be the Month AI Crossed the Exponential Threshold In the space of a single week,...
Two Cheap Hormones Extended Mouse Lifespan by 73% — And Nobody Is Talking About It
Two Cheap Drugs, 70% More Life: The Longevity Breakthrough That Big Pharma Won’t Commercialize By GRIDNET Magazine · February 19, 2026 ·...